William M Carroll

7PUBLICATIONS
67CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyImmunology not elsewhere classifiedMedical virologyPsychosocial aspects of childbirth and perinatal mental health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 03, 2026
Multiple sclerosis outcomes after cancer diagnosis in people with recorded chemotherapy exposure: A real-world MSBase study.

|Dec 26, 2025
Study protocol for a multicentre, randomised, double-blinded, placebo-controlled, multi-arm, multi-stage, trial of SpironolacTone and famciclOovir in the treatment of Progressive Multiple Sclerosis to prevent disability progression: the STOP-MS trial.

Kayla Ward, Vivien Li, Sudarshini Ramanathan

|Jun 14, 2025
Should natalizumab be used despite JC virus positivity? Yes.

William M Carroll

|Dec 03, 2024
Ocrelizumab in Early-Stage Relapsing-Remitting Multiple Sclerosis: The Phase IIIb ENSEMBLE 4-Year, Single-Arm, Open-Label Trial.

Hans-Peter Hartung, Ralph H B Benedict, Thomas Berger

|Oct 23, 2024
Disease Activity in Pregnant and Postpartum Women With Multiple Sclerosis Receiving Ocrelizumab or Other Disease-Modifying Therapies.

Wei Z Yeh, Anneke Van Der Walt, Olga G Skibina

|Dec 12, 2023
Vitamin D did not reduce multiple sclerosis disease activity after a clinically isolated syndrome.

Helmut Butzkueven, Anne-Louise Ponsonby, Mark S Stein

Pageof 2

Frequent Collaborators

4 joint publications

Tomas Kalincik

3 joint publications

Francesco Patti

3 joint publications

Vilija Jokubaitis

2 joint publications

Allan G Kermode